The recipient of a juris doctor from the University of California, Los Angeles, Michael Lin Baum is a listed member of the Bar Register of Preeminent Lawyers with over 30 years of experience. Upon earning his degree in 1985, Michael Lin Baum helped launch Baum Hedlund Aristei & Goldman, where he serves as managing partner and head of the firm's pharmaceutical litigation department.


In his role as an attorney, he leverages a wealth of knowledge in biomedical research, clinical trials, and pharmaceutical marketing in handling cases against high-profile companies such as Bayer Corp., GlaxoSmithKline, and Alpha Therapeutic. A recognized Southern California Super Lawyer, he also led litigation in regard to antidepressants Prozac, Paxil, and Zoloft.


His firm collaborated in a major effort that helped establish the black-box warning label stating these and similar drugs pose an increased risk of suicide. Prior to focusing on the pharmaceutical industry, he primarily managed cases involving commercial transportation disasters. In its 32 years of existence, his firm has settled cases against Egypt Air, China Eastern Airlines, Delta Airlines, and Ford Motor Company.

Read more
  • JoinedOctober 2017
  • OccupationBaum Hedlund Aristei & Goldman
  • Current cityLos Angeles, CA
  • CountryUS


Have something nice to say about Michael Lin Baum? Write a testimonial